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Reporting the Impact of Inferior Vena Cava Perforation By Filters
E.A. Wood, R.D. Malgor, A.P. Gasparis, N. Labropoulos, Stony Brook
University Medical Center, Stony Brook, NY
Background: Perforation of the inferior vena cava (IVC) and its
surrounding structures by filter struts is a known complication. The goal of
our review is to gauge the impact of IVC perforation by filters based on a
‘real world’ open database provided by users, facilities and manufacturers.
Methods:We reviewed 3,123 adverse events of IVC filters reported in
the Food and Drug Administration MAUDE (Manufacturer and User
Facility Device Experience) database from January 2000 to June 2011.
Outcomes of interest were incidence of IVC perforation, type of filter,
clinical presentation, and management of the perforation, including irre-
trievability rates.
Results: Three hundred sixty-seven cases of IVC perforation (12%)
were reported. The annual distribution of IVC perforation was 32 (11%)
cases, varying from 7 (6%) to 70 (17%). A three-fold increase in the number
of adverse events related to IVC filters has been noted since 2004; however,
the accrual numbers of IVC perforation have not significantly changed over
the years (Graph 1). The most common IVC filter involved in IVC perfora-
tion was the Bard G2 Filter Platform System (225, 61%), followed by the
Cook Celect in 38 cases (10%). Vein wall perforation as an incidental finding
was themost common presentation described in 171 (47%) patients. Surround-
ing organ involvement was found in 121 (33%) cases, with the aorta involved in
40 (33%) and the duodenum in 26 (21%) cases. The filter retrieval rate was 84%
regardless of vein wall perforation. Forty (11%) cases required an open proce-
dure to remove the filter due to either multi-organ involvement or a failed
attempt at retrieval. Neither major bleeding requiring further intervention nor
mortality was reported secondary to filter retrieval.
Conclusions: IVC perforations by filters remain stable over the past
decade despite increasing numbers of adverse events reported. The majority
of filters involved in perforation were retrievable and had a multi-prong
design for better attachment to the vein wall. Endovascular filter retrieval,
regardless of IVC wall perforation, is feasible and must be attempted as it is
associated with a higher success rate, and no mortality or major bleeding
events have been reported.
Factors Increasing Risk of Venous Thromboembolism After Arterial
Reconstructive Procedures
L. Mureebe, M. Ghandi, C.K. Shortell, Duke University Medical Center,
Durham, NC
Background: Although the incidence of venous thromboembolic
events (VTE) after common vascular surgical procedures repair is low, we
hypothesize that the risk of VTE may be higher in an identifiable subset of
patients. These patients may benefit from appropriate measures to prevent
VTE. To date, no study has examined and/or elucidated this issue.
Methods: The National Inpatient Survey (NIS) database from years
2000-2009 was reviewed. Records of patients who underwent open repair of
an intact abdominal aortic aneurysm (AAA), carotid endarterectomy (CEA)
aortobifemoral bypass for occlusive disease (ABF) and infrainguinal bypass
(BPG) were crossed with appropriate diagnoses for those operations. The
outcome variable evaluated was the development of VTE (deep vein throm-
bosis (DVT) or pulmonary embolism (PE)) as specified by the International
Classification of Diseases, 9th revision (ICD-9; DVT 453.4 and PE acute
and postoperative 415.19and 415.11, respectively). Perioperative and hos-
pital complications were grouped into five families (intestinal, pulmonary,
urinary, infectious and cardiac). Prior patient histories of VTE and a history
of coagulopathy were also examined. Multivariate analysis of common
complications and the association of these complications with the frequency
of VTE were conducted. Chi-squared statistics were calculated. For all
analyses, p  .05 was considered significant.
Results:The total number of discharges containing one of the procedures
of interest was 750,659. Table I details the number of discharges and the
incidence of VTE for each of the procedures. All the complications we assessed,
except for cardiac, weremore associated with patients who developed VTE. For
all procedures, the combined end point of VTE was statistically more likely in
patients with pulmonary, urinary, infectious complications or had a history of
VTE or a history of coagulopathy. For all procedures, cardiac complication did
not show an associationwith the development of VTE. Intestinal complications
were associated with VTE development in patients undergoing AAA or fem-
distal bypasses, but not CEA or ABF.
Conclusions: The overall rate of VTE in patients undergoing common
vascular surgical procedures is quite low. We have a difference in VTE risk
based on complications that occur during the hospital stay. The observation
of the low incidence of VTE in patients with cardiac complications may be
due to anticoagulation of patients with cardiac complications. This data
suggests we should consider anticoagulation in patients with multiple peri-
operative complications.






Strategy of Thrombus Removal For Extensive DVT of Pregnancy
S. Herrera, S. Thakur, S. Sunderji, R. DiSalle, S.N. Kazanjian, Z. Assi, A.J.
Comerota, The Toledo Hospital, Toledo, Ohio
Background:Extensive deep vein thrombosis (DVT) is associated with
severe postthrombotic morbidity when treated with anticoagulation alone.
Extensive DVT during pregnancy is usually treated with anticoagulation
alone, risking significant postthrombotic morbidity. Thrombolytic therapy
and operative venous thrombectomy have been safely and effectively used in
selected pregnant patients. The purpose of this report is to review the short
and long-term outcomes of eleven patients with extensive DVT of preg-
nancy treated with a strategy of thrombus removal.
Methods: From 1999-2011, eleven patients were referred for manage-
ment of extensive DVT during pregnancy, ten patients with iliofemoral/
caval DVT and one with acute superior vena caval syndrome. Gestational age
ranged from 8 to 36 weeks. All patients were offered a strategy of thrombus
removal including catheter-directed thrombolysis, pharmacomechanical
thrombolysis (PMT), and/or operative venous thrombectomy. Fetal mon-
itoring was performed throughout hospitalization. Radiation exposure was
minimized by using pelvic lead shields, limiting fluoroscopy, using small
visual fields, hand held contrast injections and avoiding magnified views.
Following intervention, leg compression was applied, patients were antico-
agulated with heparin and ambulated. Patients were converted to vitamin K
antagonists after delivery. Follow up included objective evaluation using
venous duplex and the Villalta scale.
Results: Catheter-directed thrombolysis and PMT were used in nine
patients. Two patients declined thrombolytic therapy but agreed to venous
thrombectomy, and one patient had operative thrombectomy as an adjunct
to PMT. Each patient had complete or near complete thrombus resolution
and rapid improvement in clinical symptoms. Eight patients delivered
healthy infants at term; two are currently in their third trimester, one
suffered an in-utero death 5 days post lysis due to her antiphospholipid
antibody syndrome. One patient developed two major complications, gross
hematuria requiring blood transfusion and a left popliteal artery pseudoan-
eurysm that resolved with compression ultrasound. Mean follow up was 2
years, without evidence of recurrence. Three patients had uneventful subse-
quent pregnancies. Venous duplex ultrasonography demonstrated patent
veins and normal valve function in 8 patients. Of the 10 patients with
iliofemoral DVT, 9 had Villalta scores4, and one patient had a score of 5,
consistent with mild postthrombotic syndrome.
Conclusions:Extensive DVT of pregnancy can be effectively and safely
treated with a strategy of thrombus removal, resulting in a patent venous
systemwith normal valve function, prevention of postthrombotic morbidity,
and reduction in recurrence. Operative and catheter-based techniques can
be tailored to the patient.
Value of Postoperative Compression After Surgical Treatment of Var-
icose Veins
P. Pittaluga, S. Chastanet, Riviera Veine Institut, Nice, France
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Background: It is customary to recommend wearing of elastic band
compression or compression stocking after treatment of varicose veins. We
wanted to learn through this study the benefit of wearing elastic compression
after surgical treatment of varicose veins (VVs).
Methods: We have prospectively included all patients operated on for
unilateral VVs, and distributing them into two groups: Group 1: putting on
a class 2 stocking (18mmHg) from the operating day until the postoperative
consultation (approximately 8 days afterwards). Group 2: putting on a class
2 stocking (18 mmHg) from the operating day until the following day (D1)
when it is removed.
Results: One hundred patients were included in the study, in equal
proportion (50) between group 1 and group 2. The study of the demo-
graphic, clinical and hemodynamic characteristics, show no significant dif-
ference between the two groups. All the surgical procedures had been carried
out under tumescent local anesthesia, in short ambulatory. The procedures
carried out were not significantly different between group 1 and group 2,
and had been most frequently phlebectomy with conservation of the reflux-
ing saphenous vein (ASVAL) (46% vs. 48%). The patients all returned to
postoperative consultation (on average 10.0 days on average for group 1 and
9.4 days group 2, nonsignificant: NS) for evaluation. The average pain score
(visual analog scale: VAS) was not significantly different between group 1
and group 2 (0.6 vs. 0.8). The self-evaluation by VAS of the size of
ecchymoses reported an average score without significant difference be-
tween groups 1 and 2 (1.3 vs. 1.2). The circumference of the ankle measured
was not significantly different between the operated limb and the contralat-
eral limb, for group 1 (26.2 cm vs. 25.9 cm) as well as for group 2 (26.2 cm
vs. 26.0 cm). The measurement of the quality of life by the CIVIQ ques-
tionnaire found an average score of 7.00 in group 1 vs. 8.64 in group 2 (NS).
Superficial or deep vein thrombosis was not found in any case. Lastly, 73.3%
of the patients in group 1 and 67.7% of the patients in group 2 (NS) did not
have sick leave, and the average sick leave was, respectively, 2.6 and 2.3 days
in group 1 and 2 (NS).
Conclusions: We found no value of wearing the compression after a
surgical treatment of the varicose veins beyond the 1st postoperative day for
pain, ecchymoses and the quality of life after the procedure. These results
were obtained in the context of a mini-invasive surgery carried out under
tumescent local anesthesia with immediate ambulation.
Contemporary Results Following Saphenopopliteal Transposition For
Chronic Femoral Vein Occlusion
D.M. Coleman, J.E. Rectenwald, F.C. Vandy, T.W. Wakefield, University
of Michigan, Ann Arbor, Mich
Background: Chronic occlusion of the femoral or the proximal popli-
teal vein responsible for venous insufficiency and the constellation of clinical
sequelae that ensue remains a surgical challenge that carries notable patient
morbidity and the threat of potential limb loss. Saphenopopliteal bypass
remains a surgical reconstructive option for select patients that demonstrate
patency of the popliteal vein, greater saphenous vein, saphenofemoral junc-
tion and pelvic veins. We sought to analyze our single-institution experience
with this technique.
Methods: A retrospective review of a single-center experience with
saphenopopliteal transposition was performed. Preoperative risk factors and
indications for intervention (ie: symptomatology including tissue loss) were
identified. Duration of follow-up and end-points including clinical improve-
ment, wound healing, patency and limb loss were assessed. A Kaplan-Meier
analysis for patency was performed.
Results: Seventeen patients underwent a saphenopopliteal bypass for
chronic lower extremity venous obstruction between July, 1988 and August,
2011. Median age at operation was 40 years (range, 23-69 years). There was
a male predominance noted (N12; 71%). All patients suffered from
chronic edema and venous claudication. Six patients (35%) had evidence of
venous ulceration preoperatively. Seven patients (41%) underwent a preced-
ing venous intervention (ie: iliac stenting or venous thrombolysis). Three
patients had a concomitant arteriovenous fistula created to enhance in-flow;
two patients underwent concomitant femoral-femoral venous bypass. Five
patients (29%) experienced hematoma postoperatively that required opera-
tive evacuation; in two patients compression from this hematoma resulted in
early graft occlusion. After a median follow-up of 85months (range, 2-236),
82% of patients experienced symptom improvement or near-complete symp-
tom resolution. Four of the six patients with venous ulceration healed their
wounds (67%). Of the sixteen patients that underwent Duplex follow-up,
primary patency was 68.7% and secondary patency was 75%. (Fig) One
patient required amputation and there were no deaths. This secondary
patency rate exceeds any previously published patency rate.
Conclusions: Saphenopopliteal bypass is indicated for chronic venous
stasis disease secondary to deep venous obstruction at the thigh. This venous
reconstruction option remains a satisfactory and reliable procedure that
produces clinical improvement in a selected group of patients and should be
considered in a contemporary venous surgical practice.
Liberation Procedure in the Treatment of Chronic Cerebro-Spinal Ve-
nous Insufficiency - Is Chronic Cerebro-Spinal Venous Insufficiency Re-
lated To Brain Congestive Syndrome Rather Than Multiple Sclerosis
D.J. Milic, P. Bosnjakovic, S. Vojinovic, Z. Sasa, A. Ilic, D. Stojanov,
V. Milojkovic, Clinical Centre Nis, Nis, Serbia
Background: Chronic cerebro-spinal venous insufficiency (CCSVI)
is a term developed to describe compromised flow of blood in the veins
draining the central nervous system. It has been suggested by some
authors that this condition is related to Multiple Sclerosis (MS). Balloon
angioplasty and stenting have been proposed as a treatment option for
CCSVI in MS. The proposed treatment has been termed ”liberation
procedure” though the name has been criticized for suggesting unreal-
istic results.
Methods: An open,prospective,single-center study, was performed
in order to determine the efficacy of “Liberation procedure” in the
treatment of different forms of MS (relapsing remitting,secondary pro-
gressive, primary progressive, and progressive relapsing). The evaluation
of patient’s status before the procedure, 6 and 12 months after the
procedure was performed using: Expanded Disability Status Scale
(EDSS); MSFC-Multiple sclerosis functional composite(TIMED 25-
FOOT WALK;9-HOLE PEG TEST;PASAT-Paced auditory serial test)
and SDMT-Symbol digit modalities test. The outcome of the procedure
was also analyzed using: PRO-patient related outcomes, SF-36 question-
naire,EQ-5D (EuroQol) and Functional Assessment of Multiple Sclero-
sis (FAMS) quality of life. In order to determine the effects of the
procedure blood sample from jugular vein was analyzed 24h before the
procedure and 24h, 72h and 7 days after the procedure (pH and
bicarbonate, BE, pCO2 and pO2, K, Na, CRP).
Results:Overall 205 patients completed the study (86 men and 119
women). Ninety-two patients had relapsing-remitting MS, 103 patients
had secondary progressive form and 10 patients had primary progressive
MS. Avarage patient’s age was 41.21years. The EDSS before the “Lib-
eration procedure” was 5.5021.95 (visual-0.240.71;brainstem-
1.061.29; pyramidal-3.11.16;cerebellar-2.00.99; sensory-
2.640.72; bowel/bladder- 1.140.87; cerebral 0.871.17). On the
check-up 6 and 12 months after the procedure the EDSS did not show
any statistical significant difference between the pre and post procedural
values. However, initial benefit of the procedure was seen in almost 70%
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